SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] |
|
| SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNING PER SHARE |
The
computation of basic and diluted loss per share for December 31, 2025, and December 31, 2024 excludes the common stock equivalents of
the following potentially dilutive securities because their inclusion would be anti-dilutive:
SCHEDULE OF ANTIDILUTIVE SECURITIES OF EARNING PER SHARE
| | |
December
31, 2025 | | |
December
31, 2024 | |
| | |
| | |
| |
| Stock Warrants (Exercise price
- $0.001- $0.25/share) | |
| 72,285,714 | | |
| 81,035,714 | |
| Stock Options (Exercise price - $0.1150/Share) | |
| 34,981,000 | | |
| 26,981,000 | |
| Convertible Preferred Stock | |
| 3 | | |
| 3 | |
| Common Stock Payable | |
| 1,122,311 | | |
| 1,122,311 | |
| Total | |
| 108,389,028 | | |
| 109,139,028 | |
|
| SCHEDULE OF INCOME TAX RATE RECOGNIZED |
SCHEDULE OF INCOME TAX RATE RECOGNIZED
| | |
2025 | | |
2024 | |
| Expected income tax (recovery)
expense at the statutory rate of 21% | |
$ | (760,904 | ) | |
$ | (713,777 | ) |
| Tax effect of expenses that are not deductible
for income tax purposes (net of other amounts deductible for tax purposes) | |
| 235,230 | | |
| 180,605 | |
| Change in valuation allowance | |
| 525,674 | | |
| 533,172 | |
| Provision for income taxes | |
$ | - | | |
$ | - | |
|
| SCHEDULE OF DEFERRED INCOME TAXES |
The
components of deferred income taxes are as follows:
SCHEDULE OF DEFERRED INCOME TAXES
| | |
2025 | | |
2024 | |
| | |
Years
Ended December, | |
| | |
2025 | | |
2024 | |
| Deferred tax liability: | |
$ | - | | |
$ | - | |
| Deferred tax asset | |
| | | |
| | |
| Net Operating
Loss Carryforward | |
| 6,401,803 | | |
| 5,876,129 | |
| Valuation allowance | |
| (6,401,803 | ) | |
| (5,876,129 | ) |
| Net deferred tax asset | |
| - | | |
| - | |
| Net
deferred tax liability | |
$ | - | | |
$ | - | |
|
| SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS |
The
Company has consistently applied the valuation techniques in all periods presented. The following table presents the Company’s
assets which were measured at fair value at December 31, 2025, and December 31, 2024:
SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS
| | |
December
31, 2025 | | |
December
31, 2024 | |
| | |
Fair
Value Measurement Using | | |
Fair
Value Measurement Using | |
| | |
Level
1 | | |
Level
2 | | |
Level
3 | | |
Total | | |
Level
1 | | |
Level
2 | | |
Level
3 | | |
Total | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Assets: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Investment in gold | |
$ | 494,259 | | |
$ | - | | |
$ | - | | |
$ | 494,259 | | |
$ | 627,065 | | |
$ | - | | |
$ | - | | |
$ | 627,065 | |
| Money market fund | |
$ | 1,408,399 | | |
$ | - | | |
$ | - | | |
$ | 1,408,399 | | |
$ | 607,881 | | |
$ | - | | |
$ | - | | |
$ | 607,881 | |
| Total | |
$ | 1,902,658 | | |
$ | - | | |
$ | - | | |
$ | 1,902,658 | | |
$ | 1,234,946 | | |
$ | - | | |
$ | - | | |
$ | 1,234,946 | |
|
| SCHEDULE OF GOLD IN BULLION |
The
following tables summarize activity in gold bullion for the years ended December 31, 2025 and 2024:
SCHEDULE OF GOLD IN BULLION
| Years
Ended December 31, 2025 and 2024 |
|
Ounces |
|
|
Cost |
|
|
Fair
Value |
|
| |
|
|
|
|
|
|
|
|
|
| Balance
December 31, 2023 |
|
|
239 |
|
|
$ |
2,624 |
|
|
$ |
493,236 |
|
| Net
change in unrealized gain |
|
|
- |
|
|
|
|
|
|
|
133,829 |
|
| Balance
December 31, 2024 |
|
|
239 |
|
|
$ |
2,624 |
|
|
$ |
627,065 |
|
| Cost
basis of gold bullions sold |
|
|
(129 |
) |
|
|
|
|
|
|
(243,004 |
) |
| Net
change in unrealized gain |
|
|
- |
|
|
|
|
|
|
|
110,198 |
|
| Balance
December 31, 2025 |
|
|
110 |
|
|
$ |
4,493 |
|
|
$ |
494,259 |
|
|